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The accumulation of unfolded or misfolded proteins in the endoplasmic reticulum (ER) results in the condition called ‘‘ER stress,’’ which
induces the unfolded protein response (UPR), a complex cellular process that includes changes in expression of many genes. Failure to
restore homeostasis in the ER is associated with human diseases. To identify the underlying changes in gene expression in response to ER
stress, we induced ER stress in human B cells and then measured gene expression at ten time points. We followed up those results by
studying cells from 60 unrelated people. We rediscovered genes that were known to play a role in the ER-stress response and uncovered
several thousand genes that are not known to be involved. Two of these are VLDLR and INHBE, which showed signiﬁcant increase in
expression after ER stress in B cells and in primary ﬁbroblasts. To study the links between UPR and disease susceptibility, we identiﬁed
ER-stress-responsive genes that are associated with human diseases and assessed individual differences in the ER-stress response.Many of
the UPR genes are associatedwithMendelian disorders, such asWolfram syndrome, and complex diseases, including amyotrophic lateral
sclerosis and diabetes. Data from two independent samples showed extensive individual variability in ER-stress response. Additional
analyses with monozygotic twins revealed signiﬁcant correlations within twin pairs in their responses to ER stress, thus showing
evidence for heritable variation among individuals. These results have implications for basic understanding of ER function and its
role in disease susceptibility.Introduction
The endoplasmic reticulum (ER) is the organelle where
proteins and lipids are processed1 and intracellular calcium
is regulated. When cells such as human B-lymphocytes
have to cope with increased protein loads in response to
cellular demands that require synthesis and secretion of
proteins such as immunoglobulins, they expand and cause
the differentiation of the ER.2 However, if unfolded or mis-
folded proteins accumulate in the ER, the overall result is
termed ‘‘ER stress.’’ The cell responds by the unfolded
protein response (UPR), a coordinated series of cellular
events that increase the capacity of the ER to process
the unfolded proteins and reduce the protein loads.3,4
These processes, many of which involve changes in gene
expression, are initiated when the ER chaperone protein
BiP5 dissociates from the transmembrane ER-stress-sensor
molecules, ATF6,6,7 IRE1,8 and PERK.9 ER stress occurs in
a wide variety of tissues and species and is associated
with numerous human diseases.10–14 Although ER stress
arises in normal cellular functions as well as in diseases,
many human genes and pathways involved in the process
remain to be identiﬁed. Characterization of these genes
will lead to a better understanding of ER functions and of
diseases caused by abnormalities in the UPR.
In this study, we characterized the temporal response
and individual differences in response to ER stress by
exposing B cells from unrelated individuals to tunicamycin
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expression patterns at ten time points in these cells.
Second, we focused on two time points and studied the
responses in cells from 60 individuals and a replicate
sample with 14 individuals in order to assess individual
variability in gene expression response to ER stress. Third,
we studied the genetic contribution to the ER-stress
response in genetically identical monozygotic (MZ) twins.
The results allowed us to identify a large number of human
genes involved in UPR; among them are genes such as
inhibin beta E (INHBE [MIM 612031]) and very low density
lipoprotein receptor (VLDLR [MIM 192977]), which have
not been implicated in UPR and yet are strongly induced
in B cells undergoing ER stress. We also showed that there
is extensive individual variability in gene expression
response to ER stress, and we demonstrated that there is
likely a genetic component to this variation. Many of these
variable ER-stress-responsive genes play a role in Mende-
lian disorders and complex diseases, suggesting the impor-
tance of proper ER function in human health.Materials and Methods
Samples and Induction of ER Stress
Immortalized B cells from 60 unrelated individuals (grandparents
in the HapMap CEPH-Utah pedigrees) and 26MZ twin pairs (14 of
European ancestry, 12 African American) were obtained from Cor-
iell Cell Repositories (Camden, NJ, USA). All twin pairs were
normal and apparently healthy. Zygosity testing was done at theg Program, University of Pennsylvania School of Medicine, Philadelphia, PA
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Coriell Institute (11 twin pairs) or in our lab (15 twin pairs) by gen-
otyping of 28 microsatellite markers.
Cells were grown at 37C in 5% CO2 in RPMI medium 1640
containing 15% fetal bovine serum (FBS), 2 mM L-glutamine,
and 100 U/mL penicillin/streptomycin. As a way to minimize
possible batch effects, cells from the 60 unrelated individuals
were grown in four batches, and for the twin samples, all but three
pairs were grown in only two batches, of 12 and 11 twin pairs
(24 and 22 cultures), respectively. In order to monitor effects
resulting from culturing and hybridizing cells in batches, some
cells from batch 1 were grown again with each successive batch.
To induce ER stress, we transferred cells to fresh RPMI 1640,
supplemented as above, at a concentration of 106 cells/ml, grew
them for 18 hr, and then treated them at the indicated time
points with either 500 nM thapsigargin (Sigma-Aldrich) dissolved
in DMSO (Sigma-Aldrich) or 4 mg/mL tunicamycin (Sigma-
Aldrich) in DMSO. These standard doses of thapsigargin and tuni-
camycin are used in many studies for the induction of ER
stress.15,16 These drug dosages did not lead to excessive cytoxicity.
Untreated control cultures were grown in RPMI 1640 containing
0.5% DMSO.
To monitor for ER stress, we assayed for x box-binding protein 1
(XBP1 [MIM 194355]) splicing by performing PCR with the use of
cDNA from cells as template and the following primers: forward,
50-GCTGAAGAGGAGGCGGAAG-30; reverse, 50- GTCCAGAATGC
CCAACAGG-30. Amplicons were resolved on 2.5% agarose gels.
Affymetrix Expression Arrays and Analysis
RNA was prepared from the treated and untreated cells with the
use of the RNeasy kit (QIAGEN), labeled with biotin with the use
of the GeneChip Expression 30-Ampliﬁcation One-Cycle cDNA
Synthesis Kit (Affymetrix), and hybridized to Affymetrix U133
Plus 2.0 GeneChip arrays in accordance with manufacturers’
protocols.
The microarray data were normalized with MAS5.0 and log2
transformed with Expression Console v 1.1.1 software (Affyme-
trix). Analyses were carried out on (1) genes called ‘‘present’’ in
25% ormore of the arrays (of the ~55,000 transcripts on themicro-
array, ~26,000 ﬁt this criterion and are therefore considered to be
expressed in our B cells) or, (2) for the time-course experiments,
genes that were called ‘‘present’’ in two or more time points. We
used a different selection criterion in the time-course study to
include genes that were induced at some but not all parts of the
UPR. However, we found that there are few such genes; > 80%
of the genes are either expressed or not expressed at all time
points.
DMSO was used as a solvent for thapsigargin and tunicamycin.
To account for possible effects of the DMSO, we treated cells
with DMSO alone and with thapsigargin or tunicamycin in
DMSO. For each gene, we subtracted the expression value (log2)
in the DMSO-treated samples from that (log2) in the thapsigargin-
or tunicamycin-treated cells. In order to present the response to ER
stress as a fold change (FC), we took the anti-log2 of the expression
responses.
Samples used in various analyses include the following: ﬁrst,
for the time-course study, we used ten unrelated individuals
from the collection of twins of European ancestry. The samples
were pooled at each time point and treatment andwere hybridized
onto duplicate arrays. To identify those genes that change expres-
sion levels over time, we carried out analysis of variance (ANOVA;
p < 105). Second, to identify individual variability in gene
expression response to ER stress, we analyzed data from 60720 The American Journal of Human Genetics 86, 719–729, May 14,(HapMap CEPH-Utah collection) unrelated individuals and
then replicated the ﬁndings in 14 (European twin collection) unre-
lated individuals. For each ‘‘expressed’’ gene, we carried out a
paired t test to compare gene expression in DMSO treatment
versus tunicamycin or thapsigargin treatment. Genes with a cor-
rected p < 105 (Bonferroni correction) were considered ‘‘ER-stress
responsive.’’ To determine individual variability, we calculated
variance of their expression response across 60 and 14 individuals
separately.
Fibroblasts and Keratinocytes
Primary ﬁbroblasts from the foreskin of healthy newborns were
cultured in MEM medium supplemented with 10% FBS, 2 mM
L-glutamine, and 100 U/mL penicillin/streptomycin. Keratino-
cytes (ATCC) were cultured in Dermal Cell Basal medium supple-
mentedwith Keratinocyte Growth Kit (ATCC). As with the immor-
talized B cells, the ﬁbroblasts and keratinocytes were treated with
4 mg/ml tunicamycin in DMSO or with DMSO alone. RNA was
extracted at 2, 4, and 8 hr after treatment and used for expression
analysis of VLDLR and INHBE by quantitative RT-PCR per
the manufacturer’s protocol (Applied Biosystems). Expression of
GAPDH and ACTB were used as controls for normalization, and
changes in expression were calculated relative to cells treated
with DMSO alone. Primers were as follows: INHBE forward, 50-ACT
ACAGCCAGGGAGTGTGG-30; INHBE reverse, 50-AGTGAGCAGG
GAGCTGTAGG-30; VLDLR forward, 50-TCTGTTGGACACACGTAC
CC-30; VLDLR reverse, 50-CCTCAAAGGTCAACATTTGTCA-30.
Intraclass Correlation Coefﬁcient Analysis
For each ER-stress-responsive gene, ANOVA was performed as an
assessment of differences between twin pairs, relative to differ-
ences within pairs. From the ANOVA, we computed the intraclass
correlation coefﬁcient (ICC).17,18
Cis-Acting Elements
For each ER-stress-responsive gene, we identiﬁed the RefSeq
sequence (if there were multiple RefSeq sequences for a gene, we
used the one that represented the longest transcript).Within those
sequences and 2 kb up- and downstream, we looked for exact
matches to the ER stress response element (ERSE) (CCAAT-N9-
CCACG) and the unfolded protein response element (UPRE)
(TGACGTGG/A) sequences. The positions of the ERSE or UPRE
in Table S1 (available online) correspond to those in build hg18
of the UCSC reference genome.
Disease-Susceptibility Genes
We searched Online Mendelian Inheritance in Man (OMIM) and
the GWAS catalog19 for 1752 ER-stress-responsive genes (corrected
p < 0.05, t test; FCR 1.5) to identify those that have been impli-
cated in Mendelian and complex diseases, respectively.Results
ER Stress Induced by Thapsigargin or Tunicamycin
We induced ER stress in immortalized B cells from healthy
individuals with two standard drugs, thapsigargin and
tunicamycin, that inhibit protein folding andmodiﬁcation
in the ER. Thapsigargin is an inhibitor of the sarcoplasmic
or endoplasmic reticulumCa2þ ATPase (SERCA); it depletes
the ER calcium stores and therefore prevents proper2010
Figure 1. XBP1 Splicing in Cells Treated with Thapsigargin and
Tunicamycin
Cells from two individuals with (T) and without (U) treatment
with thapsigargin and tunicamycin. In treated cells, XBP1
splicing, a hallmark of ER stress, was observed.
Figure 2. Temporal Gene Expression Pattern of Classic UPR
Genes in Cells at Baseline and Nine Time Points after Exposure
to Tunicamycin and Thapsigargin
Hierarchical clustering based on pairwise correlations for 57 classic
UPR genes. Analyses were carried out with the use of GenePattern
software.functions of molecular chaperones, such as calreticulin,
that process nascent polypeptides.20 Tunicamycin inhibits
N-glycosylation, which leads to an accumulation of under-
glycosylated proteins that cannot exit the ER.21 In the cells
that we treated with thapsigargin or tunicamycin, ER stress
was induced as shown by splicing of XBP1, a hallmark of
UPR22 (Figure 1).
Temporal Gene Expression Response to Thapsigargin
and Tunicamycin
To study the temporal response of B cells to ER stress,
we treated cells from ten healthy individuals with thapsi-
gargin or tunicamycin and used microarrays to proﬁle
gene expression at ten time points (baseline and 15
min, 30 min, 1 hr, 2 hr, 4 hr, 8 hr, 12 hr, 24 hr, and
48 hr after treatment). For each time point and treat-
ment, we pooled RNA samples from ten individuals and
hybridized them onto Affymetrix microarrays. For each
gene, we calculated changes in expression levels by
comparing the signal intensity of the treated samples
with that of the baseline and also to treatment with
DMSO alone. To identify genes that changed signiﬁcantly
at one or more time points after treatment, we carried out
an ANOVA.
In the tunicamycin-treated samples, 26,631 genes were
expressed at two or more time points. We focused on
these genes for further analysis. Among the expressed
genes, 1301 genes (5%) changed signiﬁcantly (p < 105,
ANOVA) at one or more time points after exposure to
tunicamycin. We expect to ﬁnd less than one gene that
showed this level of signiﬁcance by chance alone; thus,
we conclude that many of these genes indeed play a role
in response to tunicamycin-induced ER stress. The genes
that showed signiﬁcant changes in gene expression include
those in the classic UPR pathways, such as signaling factors
(ERN1 [MIM 604033]), chaperones (CALM1 [MIM 114180],
CANX [MIM 114217]), ER-associated degradation factors
(EDEM1 [MIM 607673], EDEM2 [MIM 610302]) and cell-
death regulators (TRIB3 [MIM 607898], DDIT3 [MIM
126337]). Figure 2 shows the temporal expression patterns
of genes in the classic UPR pathways.
To study the temporal response patterns, we clustered
the genes by their patterns of expression using correla-
tion with hierarchical clustering and carried out a post
hoc t test. Only a small number of genes showed signiﬁcant
changes in expression at the 15 and 30 min time points
(14 genes and 24 genes at p < 0.0001 [t test], respectively).
Among these early-response genes are signaling factors
(PIK3CA [MIM 171834], LCK [MIM 153390]), transcription
factors (ZNF294), and cell-cycle regulators (MCM2 [MIM
116945], CDC42 [MIM 116952]). In contrast, the late-
response genes are enriched for those involved in ER-
Golgi transport (PRKD2 [MIM 607074], COPB2 [MIM
606990]) andubiquitindegradation (UBE2B [MIM179095],
RWDD4A). The majority of genes that showed signiﬁcant
expression changes were induced or repressed within 8 hr
after tunicamycin treatment.The AmeThapsigargin and Tunicamycin Induce Similar
Changes in Gene Expression
Thapsigargin evoked a similar pattern of gene expression
changes as tunicamycin. Forty-six percent (or 596) of
1301 genes whose expression levels changed signiﬁcantlyrican Journal of Human Genetics 86, 719–729, May 14, 2010 721
Figure 3. Examples of ER-Stress-Responsive Genes that Showed Similar Expression Patterns in Response to Tunicamycin and
Thapsigargin(p < 105, ANOVA) after tunicamycin treatment also
showed signiﬁcant (p < 105) changes after thapsigargin
treatment. Many of the remaining genes showed changes
in expression after thapsigargin treatment, although they
did not reach the signiﬁcance threshold of p < 105.
Highly similar temporal patterns of expression were seen
after tunicamycin and thapsigargin treatments (Figure 2
and Figure 3). For each gene, we compared the gene expres-
sion patterns after treatments with the two drugs by calcu-
lating correlation coefﬁcients. The median correlation was
0.87 (average, 0.80, range, 0.88 to 1.0). Figure 3 shows
gene expression patterns of four genes after treatment
with the two drugs. These results suggest that most of
the expression changes are due to ER stress and are not
a speciﬁc response to tunicamycin or thapsigargin.
Cis-Acting Elements in ER-Stress-Responsive Genes
Transcription factors such as XBP1 and ATF6 coordinate
many of the gene expression changes in the UPR. There
are two well-characterized cis-acting ER-stress-responsive
elements for binding of these transcription factors. One is
the ERSE, CCAAT-N9-CCACG, where NF-Y binds to the
CCAAT part and pATF6a and pATF6b bind to the CCACG
portion.23,24 The second is the UPRE, TGACTGG/A, a
binding site for XBP1.25,26 We looked for ERSE and UPRE
sequences in the genes that showed signiﬁcant changes
(p < 105) in gene expression after tunicamycin and
thapsigargin treatments. We found that 25% of the genes722 The American Journal of Human Genetics 86, 719–729, May 14,contain one or more UPREs and that < 1% (seven genes)
contain an ERSE (see Table S1) within or 2 kb upstream
and downstream of the genic regions. Among the genes
with UPRE are those that are known to play a role in UPR,
including DNA chaperones (DNAJC3 [MIM 601184],
DNAJB6 [MIM 611332]), genes in the apoptotic pathways
(BID [MIM 601997], BCL11A [MIM 606557]), and genes
that thus far are not known to play a role in UPR, such as
VLDLR and INHBE. The seven genes with ERSE include
two genes in the classic UPR pathway (HSP90B1 [MIM
191175], CANX), three solute carriers (SLC5A3 [MIM
600444], SLC7A5 [MIM 600182], SLC33A1 [MIM 603690]),
amitochondrial ribosomal protein (MRPS6 [MIM 611973]),
and an uncharacterized gene (FAM107B). These results
allow further characterization of these genes by placing
them in either the ATF6 or the XBP1 pathway.
ER-Stress-Responsive Genes
The time-course results provide us with a temporal pattern
of gene expression responses to ER stress. However, the
number of time points limits how many samples we can
study. For the analysis, we used a pool of samples (ten indi-
viduals in the pool). Thus, genes with subtle effects would
notbedetected.Wealsodidnotobtain informationon indi-
vidual differences in response. To address these individual
differences, we picked two time points (baseline and 8 hr
after exposure) and studied changes in gene expression
8 hr after treatment with tunicamycin in 60 individuals.2010
Figure 4. Examples of Genes that Showed Significant Changes
in Response to ER Stress among 60 Unrelated Individuals
Shown are two genes (PARL and LRRC47) that showed signiﬁcant
but modest fold change after ER stress. In addition, two genes
(INHBE and VLDLR) that were not known to play a role in ER
stress showed signiﬁcant and large fold change after exposure to
tunicamycin.Among the 23,196 array probes that are expressed in our
B cells, 10,729 (46%, corresponding to 7031 genes) showed
signiﬁcant changes in gene expression with tunicamycin
treatment (p < 105, t test). The sample size allows us to
identify genes that show modest but signiﬁcant response
to ER stress. Almost half of the expressed genes showed
signiﬁcant changes in gene expression in response to ER
stress, thus illustrating the complexity of UPR. There were
2533arrayprobes (11%, corresponding to1752genes; Table
S2) that showedR 1.5-fold increase or decrease in expres-
sion. Some genes showed large changes in expression; for
example, seven that showed>10-fold change in expression
are: inhibin-beta E (INHBE), cation-transport regulator
homolog 1 (CHAC1), cell division cycle 14 (CDC14 [MIM
603504]), an expressed sequence tag (237127_at), aldehyde
dehydrogenase family 1 (ALDH1L2), solute carrier family 7
member 11 (SLC7A11 [MIM 607933]), and cystathionase
(CTH). Among them, onlyCHAC1 and SLC7A11 are known
to participate in UPR. However, genes with large fold
changes in expression are not necessarily the most bio-
logically important. Here, by studying a large sample, we
can detect subtle changes in gene expression. Many genes,
such as presenilin-associated rhomboid-like protein (PARL
[MIM 607858]) and LRRC47, showed only modest changes
in expression (< 1.5-fold), but the changes were observed
in nearly all 60 individuals (Figure 4). The consistency of
the data provides a strong suggestion that they play a role
in UPR.
To follow up these ﬁndings, we studied an additional
sample. We treated cells from an independent set of 14
unrelated individuals with thapsigargin (rather than tuni-
camycin) for 4 hr and measured changes in gene expres-
sion. Despite a smaller sample size, among the 2533 array
probes that showed signiﬁcant andR 1.5-fold changes in
expression levels in the tunicamycin-treated cells, we
found that 1500 probes showed similar changes (Table S2)
after thapsigargin treatment. This further supports the idea
that these genes are indeed responding to ER stress and not
just to tunicamycin. To study these ‘‘ER-stress-responsive
genes,’’ we ﬁrst looked for genes that belong to canonical
ER stress pathways. Known UPR genes that showed signif-
icant changes in gene expression include CHOP/DDIT3
(fold difference ¼ 8.2), IRE1/ERN1 (2.5), activating tran-
scription factor 3 (ATF3 [MIM 603148]) (2.3), homocys-
teine- and endoplasmic reticulum stress-inducible pro-
tein, ubiquitin-like domain-containing, 1 (HERPUD1 [MIM
608070]) (2.8), protein phosphatase 1, regulatory subunit
15a (GADD34/PPP1R15A [MIM 611048]) (2.3), SIL1 (BIP/
HSPA5 [MIM 608005]) (4.3), growth arrest- and dna
damage-inducible gene (GADD45A [MIM 126335]) (1.7),
eukaryotic translation initiation factor 2-alpha kinase 3
(PERK/EIF2AK3 [MIM 604032]) (1.7), and activating tran-
scription factor 4 (ATF4 [MIM 604064]) (2.5). Other
‘‘classic UPR’’ genes in which we detected signiﬁcant
changes in expression are listed in Table 1.
However, there are also many genes that have not been
reported to play a role in UPR. Among the 100 genes thatThe Ameshowed the most signiﬁcant changes and largest fold
change in gene expression, only 38 have been reported
in the literature (PubMed) as participating in UPR. Others,
such as INHBE and VLDLR, showed signiﬁcant (p ¼ 1051
and 1037, respectively) and large fold changes (23- and
7-fold changes, respectively) and yet have not been impli-
cated in UPR. Table 2 shows some of these newly identiﬁed
ER-stress-responsive genes and their functional categories
according to the Gene Ontology database.27
Very Low Density Lipoprotein Receptor and Inhibin
Beta-E
The expression levels of INHBE and VLDLR increased
signiﬁcantly after ER stress. Neither gene has been impli-
cated in UPR. The temporal patterns of expression of
INHBE and VLDLR after treatment with thapsigargin or
tunicamycin are shown in Figure 3, and their expression
levels in 60 individuals at baseline and 8 hr after thapsigar-
gin treatment are shown in Figure 4. These results showed
consistent induction of these two genes across time points
and individuals; thus conﬁrming their roles in UPR. To
determine whether the expression responses of INHBE
and VLDLR are speciﬁc to cultured B cells or are also seen
in other cell types, we induced ER stress in primary human
ﬁbroblasts and keratinocytes and measured expression
levels of these genes at 2, 4, and 8 hr after tunicamycin
treatment. In primary ﬁbroblasts, signiﬁcant (p < 0.01)
changes were observed for INHBE and VLDLR. Maximum
inductions of INHBE (4.2-fold) and VLDLR (2.9-fold) wererican Journal of Human Genetics 86, 719–729, May 14, 2010 723
Table 1. Changes in Expression Levels of Genes in the Classic UPR
Pathway
Gene Symbol p Value (t Test) Fold Change
ABCE1 1.34 3 1043 1.6
AHSA1 3.53 3 1051 1.9
ASF1B 1.55 3 1039 1.6
BAG1 1.06 3 1035 1.5
BAG2 6.35 3 1039 1.7
BAT5 5.68 3 1032 1.5
CALR 1.82 3 1038 1.7
CANX 8.20 3 1029 1.6
CCT2 1.10 3 1038 1.9
CCT6A 3.42 3 1038 1.6
CCT8 3.98 3 1011 1.5
CHAF1A 1.18 3 1035 1.9
CLGN 2.49 3 1012 2.3
COPA 5.77 3 1027 1.6
CREB3L2 2.91 3 1041 2.0
CREB3L4 5.12 3 1033 1.8
DDIT3 5.29 3 1055 8.2
DERL1 7.26 3 1035 1.7
DERL2 8.45 3 1040 2.4
DERL3 4.44 3 1034 3.9
DNAJA1 4.43 3 1040 1.8
DNAJA4 1.48 3 1010 1.7
DNAJB1 4.82 3 1041 2.5
DNAJB11 4.07 3 1042 2.8
DNAJB5 6.02 3 1029 2.1
DNAJB6 4.49 3 1029 1.9
DNAJB9 8.45 3 1037 6.0
DNAJC1 5.22 3 1038 2.2
DNAJC3 1.47 3 1037 2.5
DNAJC6 1.41 3 1014 1.8
DNAJC9 4.59 3 1035 1.5
EDEM1 1.10 3 1042 2.5
EIF2A3 2.18 3 1025 1.7
ERN1 2.27 3 1036 2.5
ERP44 1.52 3 1028 1.7
FKBP5 9.27 3 1042 1.7
GDF11 2.21 3 1015 1.7
GRPEL1 1.76 3 1034 1.7
HERPUD1 4.14 3 1037 2.8
HSP90AA1 1.03 3 1037 1.7
HSP90AB1 2.05 3 1042 1.5
Table 1. Continued
Gene Symbol p Value (t Test) Fold Change
HSP90B1 6.04 3 1033 2.0
HSPA1A 3.27 3 1033 3.0
HSPA2 6.62 3 1021 2.1
HSPA4 2.14 3 1037 1.7
HSPA4L 1.56 3 1035 1.5
HSPA8 5.31 3 1037 2.3
HSPB1 3.95 3 1029 1.5
HSPE1 2.42 3 1047 2.0
HSPH1 6.27 3 1043 2.5
HYOU1 2.49 3 1045 3.1
P4HB 3.87 3 1034 1.8
SCO1 1.03 3 1028 1.5
SEC63 6.82 3 1025 1.7
SELS 3.53 3 1045 2.8
SERPINH1 3.58 3 1011 1.5
TIMM8A 1.66 3 1034 2.4
724 The American Journal of Human Genetics 86, 719–729, May 14,seen 4 and 8 hr after ER stress, respectively. In keratino-
cytes, INHBE was not expressed, but VLDLR was expressed
and showed 2.8-fold induction after ER stress. As reported
above, the roles of INHBE and VLDLR in the ER-stress
response are further supported by the presence of unfolded
protein response element (UPRE), TGACTGG/A, a binding
site for XBP125,26 in these genes (Table S1).
Annotations of UPR-Responsive Genes
To characterize the collection of ER-stress-responsive genes,
we annotated the genes by using Gene Ontology Annota-
tions and the KEGG pathway tool. We found enrichments
of genes that are involved in RNA processing, response to
protein stimulus, and the cell cycle (see Table 3 for complete
list). Similarly, the KEGGpathway tool showed enrichment
for genes that participate in pyrimidine metabolism, cell
cycle, folate biosynthesis, and N-glycan biosynthesis (Beja-
mini-corrected p < 0.05).
UPR-Responsive Genes and Disease Susceptibility
ER stress is implicated in many human diseases, from
Mendelian disorders, such as cystic ﬁbrosis, to complex
diseases, including diabetes and neurodegenerative disor-
ders. The large number of ER-stress-responsive genes iden-
tiﬁed in this study provides us an opportunity to study the
contribution of ER stress to human diseases more compre-
hensively. We queried OMIM and the catalog of published
results from GWAS19 to identify the ER-stress-responsive
genes that have been implicated in Mendelian and
complex diseases. We found that 191 and 357 of the ER-
stress-responsive genes are disease susceptibility genes in
the OMIM and GWAS catalog, respectively.2010
Table 2. Examples of Genes that Have Not been Reported to
Participate in the ER-Stress Response
Functional Annotation Gene Symbola
p Value
(t Test)
Fold
Change
Organic acid metabolism ALDH1L2 3.13 3 1021 6.8
ALOX5AP 6.72 3 1034 3.4
ASS1 6.00 3 1037 5.9
HPDL 5.03 3 1030 0.3
PCK2 4.13 3 1057 3.4
PHGDH 5.65 3 1045 4.9
PSAT1 3.36 3 1042 5.1
SLC7A5 8.90 3 1046 3.9
Transporter CDRT4 5.33 3 1016 3.5
PHGDH 5.65 3 1045 4.9
SLC1A5 7.20 3 1051 3.8
SLC3A2 4.88 3 1056 4.8
SLC7A5 8.90 3 1046 3.9
VLDLR 4.83 3 1038 6.8
Response to stress ALOX5AP 6.72 3 1034 3.4
NFE2L1 1.25 3 1053 3.3
Kinase ALPK2 1.39 3 1031 3.7
RPS6KA2 8.26 3 1032 4.5
Glycoprotein FKBP14 3.27 3 1040 3.9
GPR84 8.84 3 1029 4.7
INHBE 2.52 3 1051 23.6
KISS1R 1.50 3 1024 0.3
SLC1A5 7.20 3 1051 3.8
SLC3A2 4.88 3 1056 4.8
SLC7A5 8.90 3 1046 3.9
TSLP 2.60 3 1022 4.3
VLDLR 4.83 3 1038 6.8
Calcium ion binding EML2 9.66 3 1041 3.9
FKBP14 3.27 3 1040 3.9
SNTB1 1.13 3 1035 3.3
VLDLR 4.83 3 1038 6.8
Data are from 60 individuals of European descent treated with tunicamycin.
a From 100 genes that showed the most significant and largest fold change in
response to ER stress.
Table 3. Functional Categories that Are Enriched in ER-Stress-
Responsive Genes
GO Annotation p Value (Benjamini)
RNA processing 3.50 3 1012
Ribosome biogenesis and assembly 7.19 3 1012
Metabolic process 1.62 3 1010
Response to protein stimulus 1.74 3 108
Nucleotide binding 3.26 3 108
Protein folding 7.67 3 108
Response to DNA damage 1.59 3 106
Helicase activity 2.04 3 106
tRNA metabolic process 3.20 3 105
Splicing 4.85 3 104
Cell cycle 7.00 3 103Examples of ER-stress-responsive genes associated with
Mendelian disorders include WFS1 (MIM 606201, associ-
ated with Wolfram syndrome 1 [MIM 222300]); CDGSH
iron sulfur domain protein 2 (CISD2 [MIM 611507], associ-
ated with Wolfram syndrome 2 [MIM 604928]); 3-prime
repair exonuclease 1 (TREX1 [MIM 606609], associated
with Aicardi-Goutie`res syndrome [MIM 225750]); ATP-
binding cassette, subfamily a, member 12 (ABCA12 [MIMThe Ame607800], associated with Harlequin ichthyosis [MIM
242500]); SIL1 (MIM 608005, associated with Marinesco-
Sjogren syndrome [MIM 248800]); DNA cross-link repair
protein 1C (DCLRE1C [MIM 605988], associated with
Omenn syndrome [MIM 603554]); and EIF2AK3 (MIM
604032, associated with Wolcott-Rallison syndrome [MIM
226980]). ER-stress-responsive genes that have been impli-
cated in complex human diseases include (1) UDP-GAL:
beta-GlcNAc beta-1,4-galactosyltransferase, polypeptide 6
(B4GALT6 [MIM 604017]); casein kinase I, gamma-3
(CSNK1G3 [MIM 604253]); inositol 1,4,5-triphosphate
receptor, type 2 (ITPR2 [MIM 600144]); RNA-binding motif
protein, single strand-interacting, 1 (RBMS1 [MIM602310]);
and ZNF746, all of which are associated with amyotrophic
lateral sclerosis, (2) tyrosine kinase, B-lymphocyte speciﬁc
(BLK [MIM 191305]); V-ETS avian erythroblastosis virus
E26 oncogene homolog 1 (ETS1 [MIM 164720]); interferon
regulatory factor 5 (IRF5 [MIM 607218]); and ubiquitin-
conjugating enzyme E2l 3 (UBE2L3 [MIM 603721]), all of
which are associated with systemic lupus erythematosus
(MIM 152700), and (3) cyclin-dependent kinase 2 (CDK2
[MIM 116953]); interferon induced with helicase C domain
protein 1 (IFIH1 [MIM 606951]); protein-tyrosine phospha-
tase, nonreceptor-type, 2 (PTPN2 [MIM 176887]); and RAS-
associated protein RAB5b (RAB5B [MIM 179514]), all of
which are associated with type 1 diabetes (MIM 222100)
(see Table 4 for additional examples). These results provide
further mechanistic suggestions of ER stress in the patho-
physiology of human diseases.
Individual Variation in Expression Response
to ER Stress
Using gene expression responses of the 60 individuals, we
assessed individual variability in response to ER stress. For
each gene, we calculated variance of fold change in
response to tunicamycin-induced ER stress, and we ranked
the genes by the variances. We found that many genesrican Journal of Human Genetics 86, 719–729, May 14, 2010 725
Table 4. ER-Stress-Responsive Genes Associated with Disease
Susceptibility
Disease
Susceptibility Genes Identified
in GWAS that Respond to ER Stress
Acute lymphoblastic
leukemia
ARID5B, ZNF230
AIDS TGFBRAP1, LTB, MICB, TNF
Alzheimer disease CLU, CR1, FAM113B, PICALM, RFC3,
TOMM40, SASH1
Amyotrophic lateral
sclerosis
B4GALT6, C9orf72, CSNK1G3, ITPR2,
RBMS1, SELL, SLC39A11, ZNF746
Bipolar disorder CTNNA2, DCTN5, PALB2, MCTP1
HDL cholesterol CTCF, FADS1, NR1H3, MMAB, MVK, TTC39B
Multiple sclerosis ASAP1, C1GALT1, CD40, CD58, CENPC1,
HLA-B, IL12A, IRF8, JAR1D2, KIF1B, METTL1,
MPHOSPH9, PTGER4, RAB38, RFK, RPL5,
SLC25A36, TNFRSF1A, WDR7, ZMIZ1
Parkinson disease AAK1, ATF6, PRRG4, QSER1
Rheumatoid arthritis REL, TRAF1, TNFRSF14
Systemic lupus
erythematosus
BLK, ETS1, HIC2, IKZF1, IRF5, PXK,
RASGRP3, TNIP1, UBE2L3
Type 1 diabetes C12orf30, C6orf173, CD69, CDK2, CTSH,
HLA-E, IFIH1, IKZF4, IL10, PGM1, PHTF1,
PTPN2, RAB5B, SUOX
Type 2 diabetes CAMK1D, CDC123, NOTCH2, THADA,
VEGFA, IRS1, WFS1
Figure 5. Extensive Individual Variation in Gene Expression
Response to ER Stress
Fold changes for ten genes in B cells from 60 unrelated individuals
at 8 hr after exposure to tunicamycin are shown. Eight of the
genes are highly variable, and two (EIF3B and SOS2) showed less
variability.showed extensive individual variation but that others
showed less variability. The fold-change values for ten
genes were plotted in Figure 5. Eight genes were highly
variable, and two (EIF3B [MIM 603917] and SOS2 [MIM
608674]) showed little individual variation in their expres-
sion responses to ER stress.
To study the variable genes, we annotated them by using
Gene Ontology. However, the variable genes did not show
enrichment of any functional groupings. Then, we looked
for known functions of the variable and less variable genes
in the ER by searching for the names of the genes and the
words ‘‘endoplasmic reticulum’’ in PubMed.We found that
signiﬁcantly more of the less variable genes were known to
have a role in the ER. Thirty of the 78 least variable genes
are found in PubMed abstracts that have the words ‘‘endo-
plasmic reticulum,’’ whereas only 13 of the 78 most vari-
able genes have such association (p ¼ 0.0001, chi-square).
This result is not too surprising, given that individual vari-
ability complicates molecular validations. Genes that are
highly variable are induced in some individuals but not
in others. Thus, these variable genes are less likely to
have been shown to play a role in the ER; experiments
with small samples would have yielded inconsistencies.
These variable responsive genes can be detected only
when a large number of samples are studied. However,
the individual variation is important because these genes
are more likely to be disease-susceptibility genes than are
genes that are less polymorphic.726 The American Journal of Human Genetics 86, 719–729, May 14,Genetic Component to ER-Stress Response
To assess whether there is a genetic component to the indi-
vidual variation in gene expression response to ER stress,
we examined the phenotypes in genetically identical MZ
twins. We induced ER stress in immortalized B cells from
14 twin pairs of European descent and 12 African Amer-
ican twin pairs, then we measured gene expression by
using the same microarrays as in the above experiments.
To evaluate twin similarity in response to ER stress, we
carried out the ANOVA separately with data from the twins
of European and African American descent. For each gene,
the ANOVA provides VA and VW, estimates of the variance
among and variance ‘‘within’’ MZ twin pairs. The fraction
VA / (VA þVW) is known as the ICC (intraclass correlation
coefﬁcient) and is a standard measure of within-pair simi-
larity.17,18 An estimate of the ICC close to its maximum
value of 1 indicates high similarity of MZ twins for that
measurement; an estimate close to 0 indicates that the
twins are no more similar for that measurement than
expected by chance. Furthermore, the ANOVA allows a
test of the signiﬁcance of the ICC; that is, a test for signif-
icant correlation within MZ twin pairs.
We used the ICC to evaluate MZ twin similarity in
response to ER stress. The ICC is not a direct indicator of
this heritable contribution, but it is the natural measure
to use with data from a sample of MZ twins.18 We consid-
ered whether to pool data from the two ethnic groups
before carrying out the ANOVA, in order to increase sample
size. However, we were concerned that there might be
underlying differences between the groups that could
result in misleading ﬁndings. For this reason, we carried
out the ICC analysis separately for the two sets of twins.
The results show that for many genes, twins are more
similar in their response to ER stress than are nontwins.
Figure 6 is an example of our ﬁndings. It shows individual
twin-pair results for gene phosphoserine phosphatase-like2010
Figure 6. Gene Expression Response of PSPHL to ER Stress of
Members of MZ Twin Pairs
ER stress was induced in B cells from 14 pairs of twins of European
descent. A vertical line connects the members of a single MZ pair.
Similar results were found for African American twins (European
descent ICC ¼ 0.8, p ¼ 9 x105; African American ICC ¼ 0.69,
p ¼ 3.3 3 103).
Table 5. Examples of UPR Genes that Showed Significant ICC
Gene Symbol
European-Descent
Twins (n ¼ 14)
African American
Twins (n ¼ 12)
Fold Changea ICCb Fold Changea ICCb
PSPHL/CO9 2.46 0.88 1.37 0.79
PHF13 1.41 0.75 1.37 0.72
ANXA2 1.25 0.79 1.25 0.67
SFRS1 1.57 0.75 1.35 0.66
CD24 2.27 0.73 2.30 0.66
BID 1.13 0.77 1.24 0.60
CLIC4 1.91 0.82 1.71 0.53
IRF2BP2 1.40 0.76 1.18 0.57
CFLAR 1.43 0.73 1.12 0.57
ARHGDIB 1.30 0.76 1.28 0.53
IFNGR1 1.50 0.78 1.52 0.51
MS4A1 1.79 0.71 2.05 0.51
FASN 1.54 0.71 1.24 0.49
SLC29A1 1.84 0.72 1.94 0.47
TMEM48 1.19 0.71 1.35 0.47
a 4 hr after ER stress.
b p < 0.005.(PSPHL [MIM 604239]). Twins are signiﬁcantly more
similar than unrelated individuals in their ER-stress
response (ICC ¼ 0.81 and 0.69 for pairs of European
descent and African American pairs, respectively). Overall,
there are 289 ER-stress responsive genes that show an
ICC > 0.5. Examples of some of these genes are listed in
Table 5. These results are based on a small sample size
(14 and 12 pairs of twins), but they are suggestive that indi-
vidual variation in expression response to ER stress is
genetically regulated.Discussion
Individual differences in the efﬁciency of the ER to carry
out its cellular functions underlie human diseases such as
autoimmune and neurodegenerative disorders. The ER is
the organelle where key cellular functions, including
protein synthesis, protein modiﬁcation, calcium mainte-
nance, and lipid synthesis, occur. To respond to cellular
needs, the ER synthesizes transmembrane proteins and
lipids that constitute most of the cell’s organelles from
the ER itself to mitochondria, Golgi, and the plasma
membrane. In cells, such as B-lymphocytes, which secrete
proteins in the form of immunoglobulins, or hepatocytes,
where lipoproteins are produced, the ER is abundant. The
efﬁciency in which cells can produce antibodies, insulin,
and lipoproteins affects the organism’s ability to ﬁght
infections, its ability to deal with sugar and fat loads, and
ultimately its susceptibility to diseases. Accumulation of
proteins in cells triggers UPR, which is a complex response
that includes changes in transcription of genes involved in
protein degradation, transport, and synthesis. In this
study, we carried out gene expression studies in cells
from a large number of individuals treated with two
ER-stress-inducing drugs, tunicamycin and thapsigargin,
to assemble a comprehensive list of genes that participate
directly and indirectly in the UPR. We ‘‘rediscovered’’ the
known genes, but we also found many genes that wereThe Amenot known to play a role in UPR. Among the top 100 genes
that showed the most signiﬁcant and highest fold induc-
tion or repression in response to ER stress, only 40% are
known ‘‘UPR genes.’’ The validity of many of the ﬁndings
is supported by ‘‘rediscovering’’ known UPR genes, consis-
tent results from two independent samples and from two
drugs that induce ER stress by different mechanisms.
Some of the ‘‘new’’ genes participate in known UPR
pathways such as protein transport and degradation,
but the roles of others, including VLDLR and INHBE,
whose expression levels were induced greatly (~7-fold
and 23-fold, respectively) in both B cells and ﬁbroblasts,
remain to be determined. VLDLR was also induced in
response to ER stress in primary keratinocytes. Hence,
these results provide a basis for reﬁning our knowledge of
known UPR pathways and for identifying new ones.
To examine the connection between ER function and
disease susceptibility, we assessed individual variation in
ER function. We found extensive variation in gene expres-
sion response to ER stress. Previously, we showed that there
is extensive variation in gene expression at baseline28 and
in response to radiation.29 Results from this study suggest
that individuals differ not only in response to external
stimuli, such as radiation, but also to cellular stress, such
as protein load. Among the genes that show variable
response to ER stress are chemokines, such as lymphotac-
tin (XCL1 [MIM 600250]), which play a key role in
immune response and are associated with disorders
such as rheumatoid arthritis [MIM 180300]30 and IgArican Journal of Human Genetics 86, 719–729, May 14, 2010 727
nephropathy [MIM 161950].31 There are also genes that
are associated with type 1 diabetes, including PTPN2,
major histocompatibility complex, class II, DR alpha
(HLA-DR1 [MIM 142860]), and interleukin 1-alpha (IL1A
[MIM 147760]),32,33 and WFS134 and CISD235 are associ-
ated with Wolfram syndromes 1 and 2, syndromic forms
of diabetes. Understanding the functions of these variable
UPR genes will provide a mechanistic link between ER
function and human diseases.
We also examined the ER-stress response in MZ twins in
order to assess genetic contributions to individual vari-
ability in response to ER stress. Results from 26 MZ twin
pairs, 14 and 12 of European and African American
descent, respectively, showed signiﬁcant MZ twin simi-
larity; the expression response for many genes is highly
correlated within the twin pairs. These results suggest
a heritable contribution to the expression response of
some genes to ER stress and the existence of germline
genetic variation that inﬂuences response to ER stress. In
genetics of gene expression studies,36,37 we and others
have shown that DNA variants inﬂuence gene expression
at baseline and in response to radiation.38–43 The results
from this study suggest that similar genetic approaches
can be used to identify DNA sequence variants that inﬂu-
ence the ER-stress response. Those results will provide
a basic understanding of regulation of the function of
the ER and provide candidate susceptibility genes for
diseases that are result of ER stress, such as diabetes.Supplemental Data
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